Nathan Wong/LinkedIn
Mar 27, 2026, 16:23
Nathan Wong: Lp(a) Testing as a Class I Recommendation in 2026 Guidelines
Nathan Wong, Professor and Director of the Heart Disease Prevention Program, Division of Cardiology at UC Irvine, shared a post on LinkedIn:
“Today is Lp(a) Awareness Day and testing it at least once in all adults is now a Class I recommendation from the new 2026 ACC/AHA/Multisociety Dyslipidemia Guideline and there’s a lot we can do to lower risk in those with elevated levels.”
American College of Cardiology shared a post on LinkedIn:
“Learn about the unique role of Lp (a) as a genetic determinant for ASCVD risk and the importance of testing for Lp (a) levels to better understand your patients’ cardiovascular health with ACC’s online course.”
Stay updated with Hemostasis Today.
-
Mar 27, 2026, 16:26Robert Talac: Platelet Concentration Gap – PRP vs Advanced PRF
-
Mar 27, 2026, 16:21Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
-
Mar 27, 2026, 16:19Laura Baglow-Micic: Register for the Transfusion Research Network for The SWiFT Trial Results Webinar
-
Mar 27, 2026, 16:18Chris Hannay: Rising Demand for Immunoglobulin Driving Plasma Industry Growth in Canada
-
Mar 27, 2026, 15:33Caitlin Raymond: A Manifesto on Three Foundational Values for a Real Culture of Wellness
-
Mar 27, 2026, 15:30Shankar Biswas: Impact of Coronary Collaterals on Mortality in STEMI
-
Mar 27, 2026, 15:21Joseph Ebubechukwu: The Hidden Impact of Elevated PCV on Patient Wellbeing
-
Mar 27, 2026, 14:53Tooba Rehman: Extending Impella 5.5 Support Beyond 14 Days in Cardiogenic Shock
-
Mar 26, 2026, 17:33Melissa Bouchard: Navigating Prosthetic Valves and Anticoagulation in Pregnancy at ACHD Hive Talks